Citadel Advisors’s Aveanna Healthcare AVAH Stock Holding History

Citadel Advisors’s Portfolio AVAH Stock Details AVAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$156K	Buy	+18,200	New	+$128K	﹤0.01%	12318
2025 Q4	–	Sell	-22,000	Closed	-$195K	–	12634
2025 Q3	$195K	Buy	+22,000	New	+$139K	﹤0.01%	11289
2025 Q1	–	Sell	-200	Closed	-$914	–	14439
2024 Q4	$914	Buy	200 +100	+100%	+$512	﹤0.01%	14255
2024 Q3	$520	Sell	100 -1,000	-91%	-$4.52K	﹤0.01%	14003
2024 Q2	$3.04K	Buy	1,100 +800	+267%	+$1.99K	﹤0.01%	13629
2024 Q1	$747	Buy	+300	New	+$724	﹤0.01%	14256
2023 Q1	–	Sell	-2,500	Closed	-$1.95K	–	14684
2022 Q4	$1.95K	Buy	+2,500	New	+$2.62K	﹤0.01%	14394

Other funds holding AVAH

BCI

Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return

JHWEPV

J.H. Whitney Equity Partners VII New Canaan, Connecticut $232M AUM 63.86% 1-Year Est. Return

NTCM

Nut Tree Capital Management New York $419M AUM 65.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OAM

Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

Citadel Advisors's AVAH Position: Q2 2026 in Review

Citadel Advisors increased its Aveanna Healthcare (AVAH) stake by 725% in Q2 2026, buying an estimated $14.2M and bringing the position to 2,285,756 shares worth $19.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2618.

Citadel Advisors first reported a position in AVAH in Q2 2021 and has held it in 17 quarters since. 216 funds tracked by Wall St. Rank hold AVAH as of Q2 2026.

Citadel Advisors held 2,285,756 shares of Aveanna Healthcare worth $19.6M as of Q2 2026.
Citadel Advisors bought 2,008,806 Aveanna Healthcare shares in Q2 2026, an estimated $14.2M.
Aveanna Healthcare made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #2618 holding.
Citadel Advisors first reported a position in Aveanna Healthcare in Q2 2021 and has held it in 17 quarters since.
216 funds tracked by Wall St. Rank held Aveanna Healthcare as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.